Evaluation of the profile of cytopathological examinations of the cervix in Brazil: a descriptive study
DOI:
https://doi.org/10.33448/rsd-v12i2.40211Keywords:
Atypical squamous cells of the cervix; Pap test; Cervical neoplasms; Descriptive epidemiology.Abstract
Objective: To evaluate the epidemiological profile of cytopathological examination and its main changes carried out in Brazil in the last 5 years. Methods: This is a quantitative descriptive epidemiological study, in which data were obtained through the Cancer Information System (SISCAN) between 2017 and 2022. Results: During the period studied, 37,020,409 cytopathological examinations of the cervix were performed in the Brazil. With regard to age, approximately 90% of the exams were in the recommended age group for cervical cancer screening, with emphasis on the drop of approximately 44% in the number of cytopathological exams performed in 2020, making it possible to correlate with the period of the pandemic by SARS- CoV-2. Most of the exams evaluated (85%) showed some benign or malignant alteration, however, only 2.9% had alterations, after excluding benign ones. Conclusion: Most alterations in the cytopathological exams were benign, whereas the malignant ones presented a similar prevalence to those in the literature, with squamous cell carcinoma being more common, followed by adenocarcinoma.
References
Comitê de Boletins de Prática – Ginecologia (2016). Boletim de Prática No. 168: Rastreamento e Prevenção do Câncer Cervical. Obstet Gynecol; 128:e111.
Crum, C.P., Huh, W.K., Einstein, M.H. (2022). Rastreio do cancro do colo do útero: A citologia e o relatório do papilomavírus humano. UpToDate. Disponível em: https://www.uptodate.com/contents/cervical-cancer-screening-the-cytology-and-human-papillomavirus-report?search=cancer%20de%20colo%20de%20utero&source=search_result&selectedTitle=13~150&usage_type=default&display_rank=12
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa. Editora Artes Médicas.
Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO) (2021). Câncer do colo do útero. São Paulo: FEBRASGO: Protocolo FEBRASGO _ Ginecologia, n. 8/Comissão Nacional Especializada em Ginecologia Oncológica.
FEBRASGO (2017). Rastreio, diagnóstico e tratamento do câncer de colo de útero. São Paulo.
Feldman, S., Goodman, A., Peipert, J. F. (2022). Triagem para câncer cervical em ambientes ricos em recursos. UpToDate. Disponível em: https://www.uptodate.com/contents/screening-for-cervical-cancer-in-resource-rich-settings?search=cancer%20de%20colo%20de%20utero&source=search_result&selectedTitle=11~150&usage_type=default&display_rank=10
Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., et al (2020). Rastreamento de câncer cervical para indivíduos com risco médio: atualização das diretrizes de 2020 da American Cancer Society. CA Cancer J Clin; 70:321.
Frumovitz, M. (2023). Câncer cervical invasivo: epidemiologia, fatores de risco, manifestações clínicas e diagnóstico. UpToDate. Disponível em: https://www.uptodate.com/contents/invasive-cervical-cancer-epidemiology-risk-factors-clinical-manifestations-and-diagnosis?search=cancer%20de%20colo%20de%20utero&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Instituto Nacional de Câncer (INCA) (2022). Dados e número sobre câncer do colo de útero: relatório anual 2022. Rio de Janeiro.
INCA (2021). Detecção precoce do câncer. Rio de Janeiro.
Jason, D. (2022). Neoplasia intraepitelial cervical: terminologia, incidência, patogênese e prevenção. UpToDate. Disponível em: https://www.uptodate.com/contents/cervical-intraepithelial-neoplasia-terminology-incidence-pathogenesis-and-prevention?search=altera%C3%A7%C3%B5es%20benignas%20citopatologico&topicRef=5428&source=see_link
Herfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M .R., McLaughlin-Drubin, M. E., et al (2012). Uma população discreta de células da junção escamocolunar implicada na patogênese do câncer cervical. Proc Natl Acad Sci US A.;109(26):10516.
Katki, H. A., Kinney, W. K., Fetterman, B., Lorey, T., Poitras, N. E., Cheung, L., et al (2013). Avaliação comparativa do risco de NIC 3+ como base para a incorporação do teste de HPV e Papanicolau nas diretrizes de rastreamento e manejo cervical. J Disfunção do Trato Genital; 17:S28.
Migowski, A. & Corrêa, F. M. (2020). Recomendações para detecção precoce de câncer durante a pandemia de covid-19 em 2021.Rev. APS; 23 (1): 235 –240
Ministério da Saúde (MS) (2022). DATASUS. SISCAN- Cito do Colo- por local de atendimento- Brasil.
MS (2016). Diretrizes brasileiras para o rastreamento do câncer do colo do útero / Instituto Nacional de Câncer José Alencar Gomes da Silva. Coordenação de Prevenção e Vigilância. Divisão de Detecção Precoce e Apoio à Organização de Rede. – 2. ed. rev. atual. – Rio de Janeiro: INCA.
Organização Mundial Da Saúde (OMS) (2007). Early detection. Geneva: WHO: Cancer control: knowledge into action: WHO guide for effective programmes, module 3. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/43743/9241547338_eng.pdf?sequence=1
OMS (2021). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: WHO.
Perkins, R. B., Guido, R. S., Castle, P. E., Chelmow, D., Einstein, M. H., Garcia, F., et al (2020). Diretrizes de Consenso de Gestão Baseada em Risco ASCCP 2019 para Testes de Rastreamento de Câncer Cervical Anormal e Precursores de Câncer. J Low Dis do Trato Genit; 24:102.
Ries, L. A .G., Melbert, D., Krapcho, M., et al (2007). SEER Cancer Statistics Review, 1975-2004. Instituto Nacional do Câncer; Bethesda, DM.
White, A., Thompson, T. D., White, M. C., Sabatino, S. A., de Moor, J., Doria-Rose, P. V., et al (2017). Uso de teste de triagem de câncer - Estados Unidos. MMWR Morb Mortal Wkly Rep; 66:201.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Berila Beatriz Dias de Almeida; Maria Adriely Cunha Ferreira; Laura Teresa Reis dos Santos; José Francisco Sobral Neto; Eduardo Paulo de Souza; Marina Schuster Monteiro; Halley Ferraro Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
